300226.SZ
300226.SZ
CNE1000013Q9
SHANGHAI GANGLIAN
Loading chart...
Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 50/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.7x).

Beta (Market Relation)
0.67x
Defensive
Volatility (5Y p.a.)
52.5% p.a.
5-Year Horizon
Max Drawdown (5Y)
-66.4%
5-Year Horizon
Sharpe Ratio
-0.20
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — -18.6%
3 Years 51.6% -50.8% -0.24 -10%
5 Years 52.5% -66.4% -0.2 -7.9%
10 Years 48.6% -73.9% -0.1 -2.3%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Critical leverage: Debt-to-Equity is at 427%.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (52.5% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -73.9% in the extended horizon.
ende